A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients
David-Neto, Elias, Triboni, Ana H K, Paula, Flavio J, Vilas Boas, Lucy S, Machado, Clarisse M, Agena, Fabiana, Latif, Acram Z A, Alencar, Cecília S, Pierrotti, Ligia C, Nahas, William C, Caiaffa-Filho, Helio H, Pannuti, Claudio S
Published in Transplantation (27.11.2014)
Published in Transplantation (27.11.2014)
Get more information
Journal Article